Julia Marie Eastland is President and CEO of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 269,381 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
n/a 12M change
Total Value Held $0

JULIA MARIE EASTLAND Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2024
SELL
Sale (or disposition) back to the issuer
-
269,381 Reduced 100.0%
0 Common Stock
Mar 11 2024
BUY
Grant, award, or other acquisition
-
31,250 Added 10.39%
269,381 Common Stock
Jan 07 2024
BUY
Grant, award, or other acquisition
-
178,500 Added 43.48%
232,003 Common Stock
Nov 26 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 48.31%
53,503 Common Stock

Also insider at

DVAX
DYNAVAX TECHNOLOGIES CORP Healthcare
GRAY
GRAYBUG VISION, INC. Healthcare
LNTH
Lantheus Holdings, Inc. Healthcare
JME

Julia Marie Eastland

President and CEO
Emeryville, CA

Track Institutional and Insider Activities on HARP

Follow Harpoon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HARP shares.

Notify only if

Insider Trading

Get notified when an Harpoon Therapeutics, Inc. insider buys or sells HARP shares.

Notify only if

News

Receive news related to Harpoon Therapeutics, Inc.

Track Activities on HARP